[Federal Register Volume 77, Number 193 (Thursday, October 4, 2012)]
[Notices]
[Pages 60722-60723]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-24498]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-790]
Certain Coenzyme Q10 Products and Methods of Making Same; Notice
of Request for Statements on the Public Interest
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the presiding administrative law
judge has issued a Final Initial Determination and Recommended
Determination on Remedy and Bond in the above-captioned investigation.
The Commission is soliciting comments on public interest issues raised
by the recommended relief, specifically a limited exclusion order with
respect to the accused products of respondents Zhejiang Medicine Co.,
Ltd., ZMC-USA, L.L.C., Xiamen Kingdomway Group Company, Pacific Rainbow
International, Mitsubishi Gas and Chemical Company, Mitsubishi Gas
Chemical America, Inc., and Shenzhou Biology and Technology Co., Ltd.
FOR FURTHER INFORMATION CONTACT: Lisa R. Barton, Acting Secretary to
the Commission, U.S. International Trade Commission, 500 E Street SW.,
Washington, DC 20436, telephone (202) 205-2000. The public version of
the complaint can be accessed on the Commission's electronic docket
(EDIS) at http://edis.usitc.gov, and will be available for inspection
during official business hours (8:45 a.m. to 5:15 p.m.) in the Office
of the Secretary, U.S. International Trade Commission, 500 E Street,
SW., Washington, DC 20436, telephone (202) 205-2000.
General information concerning the Commission may also be obtained
by accessing its Internet server (http://www.usitc.gov). The public
record for this investigation may be viewed on the Commission's
electronic docket (EDIS) at http://edis.usitc.gov. Hearing-impaired
persons are advised that information on this matter can be obtained by
contacting the Commission's TDD terminal on (202) 205-1810.
SUPPLEMENTARY INFORMATION: Section 337 of the Tariff Act of 1930
provides that if the Commission finds a violation it shall exclude the
articles concerned from the United States:
Unless, after considering the effect of such exclusion upon the
public health and welfare, competitive conditions in the United
States economy, the production of like or directly competitive
articles in the United States, and United States consumers, it finds
that such articles should not be excluded from entry.
19 U.S.C. 1337(d)(1). A similar provision applies to cease and desist
orders. 19 U.S.C. 1337(f)(1).
The Commission is interested in further development of the record
on the public interest in these investigations. Accordingly, members of
the public are invited to file submissions of no more than five (5)
pages, inclusive of attachments, concerning the public interest in
light of the administrative law judge's Recommended Determination on
Remedy and Bond issued in this investigation on September 27, 2012.
Comments should address whether issuance of an exclusion order and a
cease and desist order in this investigation would affect the public
health and welfare in the United States, competitive conditions in the
United States economy, the production of like or directly competitive
articles in the United States, or United States consumers.
In particular, the Commission is interested in comments that:
(i) Explain how the articles potentially subject to the recommended
orders are used in the United States;
(ii) Identify any public health, safety, or welfare concerns in the
United States relating to the recommended orders;
(iii) Identify like or directly competitive articles that
complainant, its licensees, or third parties make in the United States
which could replace the subject articles if they were to be excluded;
(iv) Indicate whether complainant, complainant's licensees, and/or
third party suppliers have the capacity to replace the volume of
articles potentially subject to the recommended exclusion order and/or
a cease and desist order within a commercially reasonable time; and
(v) Explain how the exclusion order and cease and desist order
would impact consumers in the United States.
Written submissions must be filed no later than by close of
business on October 29, 2012.
Persons filing written submissions must file the original document
electronically on or before the deadline stated above and submit 8 true
paper copies to the Office of the Secretary by noon the next day
pursuant to section 210.4(f) of the Commission's Rules of Practice and
Procedure (19 CFR 210.4(f)). Submissions should refer to the
investigation number (``Inv. No. 337-TA-790'') in a prominent place on
the cover page and/or the first page. (See Handbook for Electronic
Filing
[[Page 60723]]
Procedures, http://www.usitc.gov/secretary/fed_reg_notices/rules/handbook_on_electronic_ filing.pdf.) Persons with questions
regarding filing should contact the Secretary (202-205-2000).
Any person desiring to submit a document to the Commission in
confidence must request confidential treatment. All such requests
should be directed to the Secretary to the Commission and must include
a full statement of the reasons why the Commission should grant such
treatment. See 19 CFR 201.6. Documents for which confidential treatment
by the Commission is properly sought will be treated accordingly. A
redacted non-confidential version of the document must also be filed
simultaneously with any confidential filing. All non-confidential
written submissions will be available for public inspection at the
Office of the Secretary and on EDIS.
This action is taken under the authority of section 337 of the
Tariff Act of 1930, as amended (19 U.S.C. 1337), and of sections 201.10
and 210.50 of the Commission's Rules of Practice and Procedure (19 CFR
201.10, 210.50).
By order of the Commission.
Issued: September 28, 2012.
William R. Bishop,
Hearings and Meetings Coordinator.
[FR Doc. 2012-24498 Filed 10-3-12; 8:45 am]
BILLING CODE 7020-02-P